{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:11:05Z","timestamp":1790759465479,"version":"4.1.0"},"reference-count":132,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T00:00:00Z","timestamp":1635811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institutes for the Humanities","award":["R01AR071170"],"award-info":[{"award-number":["R01AR071170"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Myotonic dystrophy type 1 (DM1), the most common muscular dystrophy affecting adults and children, is a multi-systemic disorder affecting skeletal, cardiac, and smooth muscles as well as neurologic, endocrine and other systems. This review is on the cardiac pathology associated with DM1. The heart is one of the primary organs affected in DM1. Cardiac conduction defects are seen in up to 75% of adult DM1 cases and sudden death due to cardiac arrhythmias is one of the most common causes of death in DM1. Unfortunately, the pathogenesis of cardiac manifestations in DM1 is ill defined. In this review, we provide an overview of the history of cardiac studies in DM1, clinical manifestations, and pathology of the heart in DM1. This is followed by a discussion of emerging data about the utility of cardiac magnetic resonance imaging (CMR) as a biomarker for cardiac disease in DM1, and ends with a discussion on models of cardiac RNA toxicity in DM1 and recent clinical guidelines for cardiologic management of individuals with DM1.<\/jats:p>","DOI":"10.3390\/ijms222111874","type":"journal-article","created":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T12:39:42Z","timestamp":1635856782000},"page":"11874","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Cardiac Pathology in Myotonic Dystrophy Type 1"],"prefix":"10.3390","volume":"22","author":[{"given":"Mani S.","family":"Mahadevan","sequence":"first","affiliation":[{"name":"Department of Pathology, University of Virginia, Charlottesville, VA 22908, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0092-5033","authenticated-orcid":false,"given":"Ramesh S.","family":"Yadava","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Virginia, Charlottesville, VA 22908, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahua","family":"Mandal","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Virginia, Charlottesville, VA 22908, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3389\/fneur.2018.00303","article-title":"Core Clinical Phenotypes in Myotonic Dystrophies","volume":"9","author":"Wenninger","year":"2018","journal-title":"Front. Neurol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1212\/WNL.0000000000004420","article-title":"National Registry Scientific Advisory. High frequency of gastrointestinal manifestations in myotonic dystrophy type 1 and type 2","volume":"89","author":"Hilbert","year":"2017","journal-title":"Neurology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/jnnp.2008.158261","article-title":"The myotonic dystrophies: Diagnosis and management","volume":"81","author":"Turner","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/brain\/112.3.779","article-title":"Anticipation in myotonic dystrophy: Fact or fiction?","volume":"112","author":"Howeler","year":"1989","journal-title":"Brain J. Neurol."},{"key":"ref_5","first-page":"385","article-title":"Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3\u2032 end of a transcript encoding a protein kinase family member","volume":"69","author":"Brook","year":"1992","journal-title":"Cell"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1126\/science.1546326","article-title":"An unstable triplet repeat in a gene related to myotonic muscular dystrophy","volume":"255","author":"Fu","year":"1992","journal-title":"Science"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1126\/science.1546325","article-title":"Myotonic dystrophy mutation: An unstable CTG repeat in the 3\u2032 untranslated region of the gene","volume":"255","author":"Mahadevan","year":"1992","journal-title":"Science"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1136\/jmg.29.11.774","article-title":"The correlation of age of onset with CTG trinucleotide repeat amplification in myotonic dystrophy","volume":"29","author":"Hunter","year":"1992","journal-title":"J. Med. Genet."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/ana.410350116","article-title":"Myotonic dystrophy patients have larger CTG expansions in skeletal muscle than in leukocytes","volume":"35","author":"Thornton","year":"1994","journal-title":"Ann. Neurol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/BF01671719","article-title":"Myopathologische Beirtr\u00e4ge 1. \u00dcber das klinische und anatomische bild des muskelschwunds der myotoniker","volume":"37","author":"Steinert","year":"1909","journal-title":"Deutsche Zeitsch. Nervenheilkunde"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"116","DOI":"10.4103\/aian.AIAN_182_17","article-title":"\u201cDystrophia Myotonica\u201d and the Legacy of Hans Gustav Wilhelm Steinert","volume":"21","author":"Mishra","year":"2018","journal-title":"Ann. Ind. Acad. Neurol."},{"key":"ref_12","first-page":"229","article-title":"On myotonia","volume":"5","author":"Griffith","year":"1911","journal-title":"Quart. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1136\/hrt.13.3.343","article-title":"The heart in myotonia atrophica","volume":"13","author":"Spillane","year":"1951","journal-title":"Br. Heart J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0002-8703(51)90020-8","article-title":"The heart in dystrophia myotonica","volume":"41","author":"Fisch","year":"1951","journal-title":"Am. Heart J."},{"key":"ref_15","first-page":"483","article-title":"The heart in dystrophia myotonica: Report of three cases in a single family","volume":"35","author":"Miller","year":"1952","journal-title":"Rhode Island Med. J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1136\/hrt.15.3.357","article-title":"A-V dissociation in dystrophia myotonica","volume":"15","author":"Litchfield","year":"1953","journal-title":"Br. Heart J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1378\/chest.40.5.594","article-title":"Delayed conduction in dystrophica myotonia","volume":"40","author":"Soffer","year":"1961","journal-title":"Dis. Chest"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/0002-9343(62)90166-3","article-title":"The heart and lungs in myotonic muscular dystrophy","volume":"32","author":"Cannon","year":"1962","journal-title":"Am. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/0002-8703(62)90017-0","article-title":"Myotonic dystrophy with electrocardiographic abnormalities. Report of a case","volume":"63","author":"Miller","year":"1962","journal-title":"Am. Heart J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/0002-8703(63)90092-9","article-title":"Electrocardiographic abnormalities associated with myotonic dystrophy","volume":"65","author":"Payne","year":"1963","journal-title":"Am. Heart J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.0954-6820.1964.tb00655.x","article-title":"Myocardial Changes in Dystrophia Myotonica","volume":"176","author":"Arnason","year":"1964","journal-title":"Acta Med. Scand."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1136\/hrt.26.3.433","article-title":"Heart Disease as the Presenting Feature in Myotonia Atrophica","volume":"26","author":"Holt","year":"1964","journal-title":"Br. Heart J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.0954-6820.1964.tb00953.x","article-title":"The Heart in Myotonic Disease","volume":"176","author":"Orndahl","year":"1964","journal-title":"Acta Med. Scand."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0002-8703(64)90307-2","article-title":"Myotonia Dystrophica with a-V Dissociation and Stokes-Adams Attacks: A Case Report and Review of the Literature","volume":"68","author":"Petkovich","year":"1964","journal-title":"Am. Heart J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1001\/archinte.1967.00290200100008","article-title":"The heart in myotonia atrophica","volume":"119","author":"Church","year":"1967","journal-title":"Arch. Intern. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/BF02853163","article-title":"Natural history of cardiac involvement in myotonic dystrophy (Steinert\u2019s disease): A 13-year follow-up study","volume":"17","author":"Mammarella","year":"2000","journal-title":"Adv. Ther."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1056\/NEJMoa062800","article-title":"Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1","volume":"358","author":"Groh","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijcard.2011.08.037","article-title":"Cardiac manifestations of myotonic dystrophy type 1","volume":"160","author":"Petri","year":"2012","journal-title":"Int. J. Cardiol."},{"key":"ref_29","first-page":"751","article-title":"Incidence and predictors of sudden death, major conduction defects and sustained ventricular tachyarrhythmias in 1388 patients with myotonic dystrophy type 1","volume":"38","author":"Wahbi","year":"2017","journal-title":"Eur. Heart J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1001\/jama.2012.346","article-title":"Electrophysiological study with prophylactic pacing and survival in adults with myotonic dystrophy and conduction system disease","volume":"307","author":"Wahbi","year":"2012","journal-title":"JAMA"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ijcard.2014.03.088","article-title":"High prevalence of cardiac involvement in patients with myotonic dystrophy type 1: A cross-sectional study","volume":"174","author":"Petri","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1159\/000174223","article-title":"Ambulatory electrocardiographic monitoring in myotonic dystrophy (Steinert\u2019s Disease). A study of 22 patients","volume":"74","author":"Fragola","year":"1987","journal-title":"Cardiology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000174380","article-title":"24-hour electrocardiographic study in myotonic dystrophy","volume":"75","author":"Forsberg","year":"1988","journal-title":"Cardiology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/hrt.59.1.47","article-title":"Electrocardiographic findings in myotonic dystrophy","volume":"59","author":"Olofsson","year":"1988","journal-title":"Br. Heart J."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ijcard.2007.12.041","article-title":"Atrial fibrillation\/flutter in myopathies","volume":"128","author":"Finsterer","year":"2008","journal-title":"Int. J. Cardiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.nmd.2021.01.002","article-title":"Prevalence of atrial fibrillation in myotonic dystrophy type 1: A systematic review","volume":"31","author":"Russo","year":"2021","journal-title":"Neuromuscul. Disord."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/jce.12604","article-title":"Long-term arrhythmia follow-up of patients with myotonic dystrophy","volume":"26","author":"Benhayon","year":"2015","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/jce.12821","article-title":"The Role of the Atrial Electromechanical Delay in Predicting Atrial Fibrillation in Myotonic Dystrophy Type 1 Patients","volume":"27","author":"Russo","year":"2016","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/pace.12260","article-title":"Atrial flutter or fibrillation is the most frequent and life-threatening arrhythmia in myotonic dystrophy","volume":"37","author":"Schwartz","year":"2014","journal-title":"Pacing Clin. Electrophysiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1111\/jce.14211","article-title":"SERUM cardiac-specific biomarkers and atrial fibrillation in myotonic dystrophy type I","volume":"30","author":"Russo","year":"2019","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.atherosclerosis.2017.10.020","article-title":"Cardiac involvement in myotonic dystrophy: The role of troponins and N-terminal pro B-type natriuretic peptide","volume":"267","author":"Valaperta","year":"2017","journal-title":"Atherosclerosis"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1212\/01.WNL.0000144343.91136.CF","article-title":"Severe cardiac arrhythmias in young patients with myotonic dystrophy type 1","volume":"63","author":"Bassez","year":"2004","journal-title":"Neurology"},{"key":"ref_43","first-page":"118","article-title":"Atrial flutter and myotonic dystrophy in a male adolescent treated with radiofrequency catheter ablation","volume":"8","author":"Halawa","year":"2007","journal-title":"Rev. Cardiovasc. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1136\/hrt.63.2.119","article-title":"Cardiac involvement in congenital myotonic dystrophy","volume":"63","author":"Forsberg","year":"1990","journal-title":"Br. Heart J."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/mus.26716","article-title":"Clinical and genetic characteristics of childhood-onset myotonic dystrophy","volume":"60","author":"Stokes","year":"2019","journal-title":"Muscle Nerve"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Chong-Nguyen, C., Wahbi, K., Algalarrondo, V., Becane, H.M., Radvanyi-Hoffman, H., Arnaud, P., Furling, D., Lazarus, A., Bassez, G., and Behin, A. (2017). Association Between Mutation Size and Cardiac Involvement in Myotonic Dystrophy Type 1: An Analysis of the DM1-Heart Registry. Circ. Cardiovasc. Genet., 10.","DOI":"10.1161\/CIRCGENETICS.116.001526"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1136\/heart.86.4.411","article-title":"Does cytosine-thymine-guanine (CTG) expansion size predict cardiac events and electrocardiographic progression in myotonic dystrophy?","volume":"86","author":"Clarke","year":"2001","journal-title":"Heart"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0735-1097(94)00351-P","article-title":"Correlation between cardiac involvement and CTG trinucleotide repeat length in myotonic dystrophy","volume":"25","author":"Melacini","year":"1995","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00415-002-0692-6","article-title":"Cardiac involvement and CTG expansion in myotonic dystrophy","volume":"249","author":"Merlevede","year":"2002","journal-title":"J. Neurol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1212\/WNL.52.8.1658","article-title":"A 10-year study of mortality in a cohort of patients with myotonic dystrophy","volume":"52","author":"Mathieu","year":"1999","journal-title":"Neurology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.jocn.2012.09.014","article-title":"Cardiologic predictors of sudden death in patients with myotonic dystrophy type 1","volume":"20","author":"Peric","year":"2013","journal-title":"J. Clin. Neurosci."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00415-018-8773-3","article-title":"A 34-year longitudinal study on long-term cardiac outcomes in DM1 patients with normal ECG at baseline at an Italian clinical centre","volume":"265","author":"Bucci","year":"2018","journal-title":"J. Neurol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e015709","DOI":"10.1161\/JAHA.119.015709","article-title":"Cardiac Conduction Disorders as Markers of Cardiac Events in Myotonic Dystrophy Type 1","volume":"9","author":"Itoh","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0960-8966(03)00138-X","article-title":"Relation of CTG expansion and clinical variables to electrocardiogram conduction abnormalities and sudden death in patients with myotonic dystrophy","volume":"13","author":"Sabovic","year":"2003","journal-title":"Neuromuscul. Disord."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1056\/NEJM195409232511306","article-title":"The heart in dystrophia myotonica; report of an autopsied case","volume":"251","author":"Fisch","year":"1954","journal-title":"N. Engl. J. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/path.1711250407","article-title":"Cardiac pathology in chronic myopathy, with particular reference to dystrophia myotonica","volume":"125","author":"Franks","year":"1978","journal-title":"J. Pathol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/0002-8703(73)90338-4","article-title":"Electrophysiological and histological abnormalities of the heart in myotonic dystrophy","volume":"86","author":"Uemura","year":"1973","journal-title":"Am. Heart J."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1136\/jcp.31.11.1057","article-title":"Myotonia dystrophica with heart involvement: An electron microscopic study of skeletal, cardiac, and smooth muscle","volume":"31","author":"Ludatscher","year":"1978","journal-title":"J. Clin. Pathol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0002-9343(79)90795-2","article-title":"Cardiac abnormalities in myotonic dystrophy. Electrophysiologic and histopathologic studies","volume":"67","author":"Motta","year":"1979","journal-title":"Am. J. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/0735-1097(88)91547-1","article-title":"Pathology of the cardiac conduction system in myotonic dystrophy: A study of 12 cases","volume":"11","author":"Nguyen","year":"1988","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_61","first-page":"27","article-title":"Pathohistological changes in endomyocardial biopsy specimens in patients with myotonic dystrophy","volume":"41","author":"Pavlovic","year":"1999","journal-title":"Panminerva Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1161\/CIRCEP.108.785865","article-title":"Cardiac myotonic dystrophy mimicking arrhythmogenic right ventricular cardiomyopathy in a young sudden cardiac death victim","volume":"1","author":"Christensen","year":"2008","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2169\/internalmedicine.44.129","article-title":"Re-entry circuit in ventricular tachycardia due to focal fatty-fibrosis in a patient with myotonic dystrophy","volume":"44","author":"Muraoka","year":"2005","journal-title":"Intern. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1083\/jcb.128.6.995","article-title":"Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues","volume":"128","author":"Taneja","year":"1995","journal-title":"J. Cell Biol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1161\/01.RES.0000193598.89753.e3","article-title":"Nuclear RNA foci in the heart in myotonic dystrophy","volume":"97","author":"Mankodi","year":"2005","journal-title":"Circ. Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/ng1857","article-title":"Reversible model of RNA toxicity and cardiac conduction defects in myotonic dystrophy","volume":"38","author":"Mahadevan","year":"2006","journal-title":"Nat. Genet."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Kim, E.Y., Barefield, D.Y., Vo, A.H., Gacita, A.M., Schuster, E.J., Wyatt, E.J., Davis, J.L., Dong, B., Sun, C., and Page, P. (2019). Distinct pathological signatures in human cellular models of myotonic dystrophy subtypes. JCI Insight, 4.","DOI":"10.1172\/jci.insight.122686"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/hmg\/ddy432","article-title":"Transcriptome alterations in myotonic dystrophy skeletal muscle and heart","volume":"28","author":"Wang","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"11067","DOI":"10.1038\/ncomms11067","article-title":"Splicing misregulation of SCN5A contributes to cardiac-conduction delay and heart arrhythmia in myotonic dystrophy","volume":"7","author":"Freyermuth","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.3389\/fphys.2018.01372","article-title":"SCN5A Variants: Association with Cardiac Disorders","volume":"9","author":"Li","year":"2018","journal-title":"Front. Physiol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/jcp.21451","article-title":"Alternative splicing of Nav1.5: An electrophysiological comparison of \u2018neonatal\u2019 and \u2018adult\u2019 isoforms and critical involvement of a lysine residue","volume":"216","author":"Onkal","year":"2008","journal-title":"J. Cell. Physiol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e010393","DOI":"10.1161\/JAHA.118.010393","article-title":"CRISPR-Mediated Expression of the Fetal Scn5a Isoform in Adult Mice Causes Conduction Defects and Arrhythmias","volume":"7","author":"Pang","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1136\/hrt.40.11.1262","article-title":"Noninvasive assessment of left ventricular function in myotonic muscular dystrophy","volume":"40","author":"Venco","year":"1978","journal-title":"Br. Heart J."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1001\/archneur.1980.00500540051004","article-title":"Echocardiographic evaluation of cardiac abnormalities in Duchenne\u2019s dystrophy and myotonic muscular dystrophy","volume":"37","author":"Reeves","year":"1980","journal-title":"Arch. Neurol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0002-8703(82)90644-5","article-title":"Left ventricular relaxation, mitral valve prolapse, and intracardiac conduction in myotonia atrophica: Assessment by digitized echocardiography and noninvasive His bundle recording","volume":"104","author":"Gottdiener","year":"1982","journal-title":"Am. Heart J."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/0002-9149(93)90919-4","article-title":"Left ventricular myocardial function in myotonic dystrophy","volume":"71","author":"Badano","year":"1993","journal-title":"Am. J. Cardiol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.1995.03530100053034","article-title":"Cardiac involvement in a large kindred with myotonic dystrophy. Quantitative assessment and relation to size of CTG repeat expansion","volume":"274","author":"Tokgozoglu","year":"1995","journal-title":"JAMA"},{"key":"ref_78","first-page":"551","article-title":"Echocardiographic findings in dystrophia myotonica (Steinert\u2019s disease)","volume":"14","author":"Sonaglioni","year":"1984","journal-title":"G Ital. Cardiol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF02219718","article-title":"The heart in muscular dystrophy: An electrocardiographic and ultrasound study of 20 patients","volume":"241","author":"Berlit","year":"1991","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1159\/000177398","article-title":"Doppler echocardiographic assessment of left ventricular diastolic function in myotonic dystrophy","volume":"88","author":"Fragola","year":"1997","journal-title":"Cardiology"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0002-9149(03)00534-4","article-title":"Myocardial tissue velocity reduction is correlated with clinical neurologic severity in myotonic dystrophy","volume":"92","author":"Fung","year":"2003","journal-title":"Am. J. Cardiol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.nmd.2003.11.005","article-title":"Subclinical cardiac involvement in myotonic dystrophy manifesting as decreased myocardial Doppler velocities","volume":"14","author":"Vinereanu","year":"2004","journal-title":"Neuromuscul. Disord."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ijcard.2006.06.056","article-title":"Early detection of biventricular involvement in myotonic dystrophy by tissue Doppler","volume":"118","author":"Parisi","year":"2007","journal-title":"Int. J. Cardiol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ijcard.2009.03.084","article-title":"Ventricular dysfunction in type 1 myotonic dystrophy: Electrical, mechanical, or both?","volume":"143","author":"Lindqvist","year":"2010","journal-title":"Int. J. Cardiol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.echo.2009.07.004","article-title":"Early left ventricular structural myocardial alterations and their relationship with functional and electrical properties of the heart in myotonic dystrophy type 1","volume":"22","author":"Bongiorni","year":"2009","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.hrthm.2012.06.032","article-title":"Assessment of cardiac involvement in myotonic muscular dystrophy by T1 mapping on magnetic resonance imaging","volume":"9","author":"Turkbey","year":"2012","journal-title":"Heart Rhythm"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3389\/fneur.2020.00192","article-title":"Rare Disease: Cardiac Risk Assessment with MRI in Patients with Myotonic Dystrophy Type 1","volume":"11","author":"Ali","year":"2020","journal-title":"Front. Neurol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12968-019-0535-6","article-title":"Myocardial fibrosis by late gadolinium enhancement cardiovascular magnetic resonance in myotonic muscular dystrophy type 1: Highly prevalent but not associated with surface conduction abnormality","volume":"21","author":"Cardona","year":"2019","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s00392-019-01414-0","article-title":"Non-invasive evaluation of the relationship between electrical and structural cardiac abnormalities in patients with myotonic dystrophy type 1","volume":"108","author":"Chmielewski","year":"2019","journal-title":"Clin. Res. Cardiol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12968-014-0059-z","article-title":"Myocardial fibrosis in patients with myotonic dystrophy type 1: A cardiovascular magnetic resonance study","volume":"16","author":"Petri","year":"2014","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"e009100","DOI":"10.1161\/CIRCIMAGING.119.009100","article-title":"Comprehensive Cardiac Magnetic Resonance for Assessment of Cardiac Involvement in Myotonic Muscular Dystrophy Type 1 and 2 Without Known Cardiovascular Disease","volume":"12","author":"Luetkens","year":"2019","journal-title":"Circ. Cardiovasc. Imag."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1532-429X-14-48","article-title":"Structural and functional cardiac changes in myotonic dystrophy type 1: A cardiovascular magnetic resonance study","volume":"14","author":"Hermans","year":"2012","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1136\/heartjnl-2015-308517","article-title":"Structural and electrical cardiac abnormalities are prevalent in asymptomatic adults with myotonic dystrophy","volume":"102","author":"Choudhary","year":"2016","journal-title":"Heart"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Sanchez, F., Weitz, C., Gutierrez, J.M., Mestroni, L., Hanneman, K., and Vargas, D. (2021). Cardiac MR Imaging of Muscular Dystrophies. Curr. Probl. Diagn. Radiol.","DOI":"10.1067\/j.cpradiol.2020.12.010"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1161\/CIRCRESAHA.116.307974","article-title":"T1 Mapping in Characterizing Myocardial Disease: A Comprehensive Review","volume":"119","author":"Puntmann","year":"2016","journal-title":"Circ. Res."},{"key":"ref_96","first-page":"202","article-title":"Cardiovascular Magnetic Resonance in Cardiology Practice: A Concise Guide to Image Acquisition and Clinical Interpretation","volume":"69","author":"Hinojar","year":"2016","journal-title":"Rev. Esp. Cardiol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"H733","DOI":"10.1152\/ajpheart.00339.2017","article-title":"Guidelines for measuring cardiac physiology in mice","volume":"314","author":"Lindsey","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s12265-011-9275-1","article-title":"Emerging MRI methods in translational cardiovascular research","volume":"4","author":"Vandsburger","year":"2011","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12968-016-0308-4","article-title":"Cardiac T1 Mapping and Extracellular Volume (ECV) in clinical practice: A comprehensive review","volume":"18","author":"Haaf","year":"2016","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1136\/heartjnl-2019-315560","article-title":"Myocardial fibrosis: Why image, how to image and clinical implications","volume":"105","author":"Bing","year":"2019","journal-title":"Heart"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/oxfordjournals.eurheartj.a061011","article-title":"Cardiac involvement in patients with myotonic dystrophy: Characteristic features of magnetic resonance imaging","volume":"16","author":"Raisaro","year":"1995","journal-title":"Eur. Heart J."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/mrm.22417","article-title":"QRS prolongation in myotonic muscular dystrophy and diffuse fibrosis on cardiac magnetic resonance","volume":"64","author":"Nazarian","year":"2010","journal-title":"Magn. Reson. Med."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Dastidar, S., Majumdar, D., Tipanee, J., Singh, K., Klein, A.F., Furling, D., Chuah, M.K., and VandenDriessche, T. (2021). Comprehensive transcriptome-wide analysis of spliceopathy correction of myotonic dystrophy using CRISPR-Cas9 in iPSCs-derived cardiomyocytes. Mol. Ther.","DOI":"10.1016\/j.ymthe.2021.08.004"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1038\/s41598-021-82007-8","article-title":"iPSC-derived cardiomyocytes from patients with myotonic dystrophy type 1 have abnormal ion channel functions and slower conduction velocities","volume":"11","author":"Poulin","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_105","first-page":"1569","article-title":"Pentamidine rescues contractility and rhythmicity in a Drosophila model of myotonic dystrophy heart dysfunction","volume":"8","author":"Chakraborty","year":"2015","journal-title":"Dis. Model Mech."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1038\/s41598-017-02829-3","article-title":"Expanded CCUG repeat RNA expression in Drosophila heart and muscle trigger Myotonic Dystrophy type 1-like phenotypes and activate autophagocytosis genes","volume":"7","author":"Chakraborty","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3389\/fneur.2018.00473","article-title":"Modeling of Myotonic Dystrophy Cardiac Phenotypes in Drosophila","volume":"9","author":"Chakraborty","year":"2018","journal-title":"Front. Neurol."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Chakraborty, M., Sellier, C., Ney, M., Pascal, V., Charlet-Berguerand, N., Artero, R., and Llamusi, B. (2018). Daunorubicin reduces MBNL1 sequestration caused by CUG-repeat expansion and rescues cardiac dysfunctions in a Drosophila model of myotonic dystrophy. Dis. Model Mech., 11.","DOI":"10.1242\/dmm.032557"},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Auxerre-Plantie, E., Nakamori, M., Renaud, Y., Huguet, A., Choquet, C., Dondi, C., Miquerol, L., Takahashi, M.P., Gourdon, G., and Junion, G. (2019). Straightjacket\/alpha2delta3 deregulation is associated with cardiac conduction defects in myotonic dystrophy type 1. eLife, 8.","DOI":"10.7554\/eLife.51114"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Gladman, J.T., Mandal, M., Srinivasan, V., and Mahadevan, M.S. (2013). Age of onset of RNA toxicity influences phenotypic severity: Evidence from an inducible mouse model of myotonic dystrophy (DM1). PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0072907"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1093\/hmg\/ddaa060","article-title":"Systemic therapy in an RNA toxicity mouse model with an antisense oligonucleotide therapy targeting a non-CUG sequence within the DMPK 3\u2019UTR RNA","volume":"29","author":"Yadava","year":"2020","journal-title":"Human Mol. Genet."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1172\/JCI32308","article-title":"Elevation of RNA-binding protein CUGBP1 is an early event in an inducible heart-specific mouse model of myotonic dystrophy","volume":"117","author":"Wang","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Rao, A.N., Campbell, H.M., Guan, X., Word, T.A., Wehrens, X.H., Xia, Z., and Cooper, T.A. (2021). Reversible cardiac disease features in an inducible CUG repeat RNA-expressing mouse model of myotonic dystrophy. JCI Insight, 6.","DOI":"10.1172\/jci.insight.143465"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Tylock, K.M., Auerbach, D.S., Tang, Z.Z., Thornton, C.A., and Dirksen, R.T. (2020). Biophysical mechanisms for QRS- and QTc-interval prolongation in mice with cardiac expression of expanded CUG-repeat RNA. J. Gen. Physiol., 152.","DOI":"10.1085\/jgp.201912450"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1126\/science.289.5485.1769","article-title":"Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat","volume":"289","author":"Mankodi","year":"2000","journal-title":"Science"},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Huguet, A., Medja, F., Nicole, A., Vignaud, A., Guiraud-Dogan, C., Ferry, A., Decostre, V., Hogrel, J.Y., Metzger, F., and Hoeflich, A. (2012). Molecular, physiological, and motor performance defects in DMSXL mice carrying >1000 CTG repeats from the human DM1 locus. PLoS Genet., 8.","DOI":"10.1371\/journal.pgen.1003043"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.nmd.2014.11.018","article-title":"Abnormal sodium current properties contribute to cardiac electrical and contractile dysfunction in a mouse model of myotonic dystrophy type 1","volume":"25","author":"Algalarrondo","year":"2015","journal-title":"Neuromuscul. Disord."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1172\/JCI5346","article-title":"DMPK dosage alterations result in atrioventricular conduction abnormalities in a mouse myotonic dystrophy model","volume":"103","author":"Berul","year":"1999","journal-title":"J. Clin. Investig."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/ng0796-316","article-title":"Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice","volume":"13","author":"Jansen","year":"1996","journal-title":"Nat. Genet."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1093\/hmg\/ddw266","article-title":"Dmpk gene deletion or antisense knockdown does not compromise cardiac or skeletal muscle function in mice","volume":"25","author":"Carrell","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3389\/fneur.2018.00519","article-title":"Of Mice and Men: Advances in the Understanding of Neuromuscular Aspects of Myotonic Dystrophy","volume":"9","author":"Braz","year":"2018","journal-title":"Front. Neurol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/hmg\/ddp570","article-title":"Heart-specific overexpression of CUGBP1 reproduces functional and molecular abnormalities of myotonic dystrophy type 1","volume":"19","author":"Koshelev","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1002\/emmm.201303275","article-title":"Compound loss of muscleblind-like function in myotonic dystrophy","volume":"5","author":"Lee","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Chou, C.C., Chang, P.C., Wei, Y.C., and Lee, K.Y. (2017). Optical Mapping Approaches on Muscleblind-Like Compound Knockout Mice for Understanding Mechanistic Insights Into Ventricular Arrhythmias in Myotonic Dystrophy. J. Am. Heart Assoc., 6.","DOI":"10.1161\/JAHA.116.005191"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"9042","DOI":"10.1038\/srep09042","article-title":"Loss of muscleblind-like 1 results in cardiac pathology and persistence of embryonic splice isoforms","volume":"5","author":"Dixon","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1126\/science.1088583","article-title":"A muscleblind knockout model for myotonic dystrophy","volume":"302","author":"Kanadia","year":"2003","journal-title":"Science"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.devcel.2020.01.037","article-title":"Aberrant Expression of a Non-muscle RBFOX2 Isoform Triggers Cardiac Conduction Defects in Myotonic Dystrophy","volume":"52","author":"Misra","year":"2020","journal-title":"Dev. Cell"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/nsmb.2067","article-title":"Misregulation of miR-1 processing is associated with heart defects in myotonic dystrophy","volume":"18","author":"Rau","year":"2011","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.celrep.2013.12.025","article-title":"The Mef2 transcription network is disrupted in myotonic dystrophy heart tissue, dramatically altering miRNA and mRNA expression","volume":"6","author":"Kalsotra","year":"2014","journal-title":"Cell Rep."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/hmg\/dds478","article-title":"Expanded CTG repeats trigger miRNA alterations in Drosophila that are conserved in myotonic dystrophy type 1 patients","volume":"22","author":"Zuniga","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"e014006","DOI":"10.1161\/JAHA.119.014006","article-title":"Clinical Care Recommendations for Cardiologists Treating Adults with Myotonic Dystrophy","volume":"9","author":"McNally","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.drudis.2021.03.024","article-title":"Myotonic dystrophy type 1 drug development: A pipeline toward the market","volume":"26","author":"Artero","year":"2021","journal-title":"Drug Discov. Today"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/21\/11874\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:24:34Z","timestamp":1760167474000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/21\/11874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,2]]},"references-count":132,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["ijms222111874"],"URL":"https:\/\/doi.org\/10.3390\/ijms222111874","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,2]]}}}